April 2, 2026 - 11:48

Cerrado Gold Inc. has announced its financial and operational results for the fourth quarter and full year ended December 31, 2025. The company reported annual production of 50,238 gold equivalent ounces (GEO), achieving its stated guidance. The all-in sustaining cost (AISC) for the year was US$1,746 per ounce, also aligning with previous forecasts.
Financially, the company demonstrated robust performance with an adjusted EBITDA of $22.3 million for the fourth quarter and $46.1 million for the full 2025 year. Cerrado Gold exited the year in a solid financial position, holding a cash balance of over $22 million. The company also highlighted the successful completion of its hedging program, which now allows it to maintain full exposure to the current strong gold price environment.
Looking ahead, Cerrado Gold has provided initial production guidance for 2026, forecasting between 50,000 and 60,000 GEO. The company noted that this production is expected to be weighted toward the second half of the year. Management will host a conference call to discuss these results in greater detail.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...